ArticleNPJ precision oncology2021
Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.
Xiahui Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it